Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing
Introduction
Alzheimer's disease (AD) is one of the biggest health challenges worldwide, with approximately 50 million people currently diagnosed and rates of disease expected to rise in the next 30 years (Alzheimer's Disease International, 2015). Alzheimer's disease is characterised by amyloid plaque build-up, tau hyperphosphorylation, neurodegeneration and cognitive decline (Jack et al., 2013). Due to this increasing burden of disease, AD has been the subject of intense research for many years. In this time, numerous animal models of AD have been generated, with many potential treatments rescuing cognitive symptoms in a wide variety of models. However, all these treatments have failed to halt progression of the disease in clinical trials. Most preclinical animal studies focus on the assessment of hippocampal deficits as an outcome of treatment efficacy. In the clinic however, other early cognitive changes are seen in AD patients including those in executive function. A greater focus on executive function in preclinical animal models is warranted in order to improve the predictive power of these models to determine how effective treatments will be in the clinic.
Patients with mild cognitive impairment (MCI) and early AD patients show executive function deficits on a wide variety of tasks including Tower of London, Stroop Colour-Word Test, Ravens Coloured Progressive Matrices, Ruff Figural Fluency Test, Colour Trails Test Part B, category fluency, backwards digit span, and the Modified Card Sorting Task (Andriuta et al., 2018; Baudic et al., 2006; Huang et al., 2017; Ramanan et al., 2017). In these tasks, patients show attenuated task acquisition and performance, indicatative of prefrontal cortex (PFC) dysfunction (Levy-Gigi et al., 2011). More importantly, executive dysfunction, especially on the Trailmaking Part B test, is predictive of cognitive decline (Mez et al., 2013) and MCI to AD conversion (Albert et al., 2001; Ewers et al., 2012; Gomar et al., 2011; Huang et al., 2017; Johnson et al., 2009). As executive function deficits occur early and, importantly, have the potential to predict cognitive decline and MCI to AD conversion, these symptoms are of great clinical interest but, to date, have not been the focus of testing treatment efficacy in preclinical animal models.
Amyloid-driven mouse models of AD have been shown to have multiple executive function deficits early in their progression. Some models have shown deficits in reversal learning, which assesses a facet of executive function called behavioural flexibility (Chudasama, 2011). Briefly, the animal must first learn one association or rule (i.e. the location of platform in a pool or a stimulus-reward pairing), which is then reversed (i.e. the platform is moved to a different location or a different stimulus is now rewarded). Many AD models have shown reversal impairments in spatial maze-based tasks like Morris water maze (Baruch et al., 2015; Hooijmans et al., 2009; Jankowsky et al., 2005; Marchese et al., 2014; Musilli et al., 2013; Papadopoulos et al., 2013; Stover and Brown, 2012), T water maze (Dong et al., 2005; Filali et al., 2012, 2011; Filali and Lalonde, 2009), cheeseboard (Cheng et al., 2013) and Barnes maze (Stover et al., 2015) as well as olfactory (Girard et al., 2014, Guérin et al., 2009), digging (Shirey et al., 2009; Zhuo et al., 2008) and place preference (Masuda et al., 2016) reversal tasks. AD models have also shown deficits in instrumental extinction, another test of executive function, where the animal must learn to stop responding to a conditioned stimulus (i.e. a stimuli that previously indicated a reward or punishment). Extinction tasks are similar to reversal tasks in that an animal must learn to adjust a stimulus/outcome association, but without having to learn a new rule. AD models show enhanced extinction in rewarded tasks (Romberg et al., 2013) and a mix of attenuated and enhanced extinction in aversive tasks like fear conditioning (Bonardi et al., 2011; Cheng et al., 2019) and conditioned taste aversion (Hanna et al., 2009; Janus et al., 2004; Pardon et al., 2009; Ramírez-Lugo et al., 2009; Rattray et al., 2010). However, the vast majority of tasks applied to AD mouse models either rely on aversive environments or are ethologically relevant to mice; thus they are not analogous to tasks performed clinically, where the patient is responding to stimuli on paper or a screen in a calm environment. As such, we need a paradigm that can assess executive function in non-aversive, human relevant conditions.
Touchscreen testing is a relatively new paradigm to behaviourally test AD mouse models with great translational potential (Shepherd et al., 2016). To date, 3 AD mouse models, the TgCRND8, APPPS1-21 and APPSwDI/Nos2-/- mice, have undergone characterisation of executive function using reversal and extinction paradigms in touchscreens. Contrary to predictions from previously used aversive tasks, TgCRND8 mice show both accelerated reversal and extinction in touchscreens compared to WT mice. This is not due to an accelerated ‘forgetting’ of the first stimulus/reward association, as TgCRND8 mice show intact retention memory for the initial stimulus (Romberg et al., 2013). Conversely, APPSwDI/Nos2-/- mice showed an attenuation of reversal in the touchscreen testing paradigm (Piiponniemi et al., 2017). The APPPS1-21 model showed reduced accuracy in reversal compared to their WT counterparts at 6 and 9 months (Van den Broeck et al., 2019). However, the APPPS1-21 animals performed significantly less trials throughout reversal, thus it is not possible to ascertain if this is a learning or motivational deficit. These conflicting and unclear results highlight the need for more studies focusing on executive function in AD mouse models.
One of the most commonly characterised AD mouse models, the APP/PS1 mouse has not yet been characterised on touchscreen-based executive function tasks. Given previous reports showing slower acquisition of reversal Morris water maze (MWM) at 8 months of age (Hooijmans et al., 2009; Jankowsky et al., 2005; Stover and Brown, 2012) and left-right discrimination learning at 6-9 months old (Filali et al., 2011, 2009) in APP/PS1 mice, we aimed to assess whether reversal learning was impaired in this mouse model using the pairwise discrimination and reversal task. Conflicting findings exist for extinction learning in APP/PS1 mice, with reports of both attenuated (Bonardi et al., 2011) and enhanced extinction to aversive extinction tasks (Cheng et al., 2019; Ramírez-Lugo et al., 2009). When assessed in positively rewarded extinction tasks at 4-8 months of age, APP/PS1 mice did not demonstrate any deficits (Bonardi et al., 2011; Cheng et al., 2013). To resolve this conflict, we set out to test if APP/PS1 mice would show deficits in reward-based executive function tasks using the rodent touchscreen paradigm. We chose to assess 12-month-old and 24-month-old animals on reversal and extinction learning, and 12, 16 and 26-month-old mice in extinction. We chose 12 months of age as this is the best-characterised age in APP/PS1 mice and we wanted this study to be comparable to as many previous studies as possible, and a 24-month-old age group would confirm if a deficit would ever develop in reversal learning. We added the 16-month-old group into extinction as 26-month-old animals struggled to perform the task. We hypothesised that APP/PS1 mice would develop executive function deficits in both appetitive reversal and extinction tasks.
Section snippets
Animals
APP/PS1 mice (APPswe/PS1∆E9 on a C57BL/6J;C3H hybrid background, Jax strain #4462) were obtained from Jackson Laboratory and bred onsite in the SPF facility at the Florey Institute of Neuroscience and Mental Health (Parkville, VIC, Australia). Male APP/PS1 and wildtype littermates (WT) mice from 12-26 months of age were used in experimental procedures. In the results sections, groups of animals are referred to by the rounded average age of the group. Female mice were not tested due to
Pairwise discrimination is unaffected in 12- and 21-month-old APP/PS1 mice
For PD, animals were trained to choose one diagonal contrast-grating image over another for a strawberry milk reward. At 12 months of age, APP/PS1 animals took the same number of trials to reach the criterion where they were deemed to have learned the task (Fig. 1A, χ2 (1) = 0.05, p = 0.82). Regression models were then used to analyse this data at the trial level, to assess the likelihood (or odds) that the APP/PS1 mice would choose the correct, rewarded image compared to the incorrect,
Discussion
In this study, we have shown a progressive executive function deficit in APP/PS1 mice, with intact performance in the reversal learning task at 13 months of age and a deficit appearing by 22 months of age. This impairment was independent of changes in pairwise discrimination and any genotype-mediated structural and functional changes to the retina. Extinction learning was assessed at 13, 16 and 26 months of age, and was found to first be impaired by 16 months. This is the first demonstration of
Disclosure statement
The authors report no conflicts of interest.
A.S is supported by an Australian Government Research Training Program Scholarship and Yulgilbar top-up scholarship. A.M.Z.J is supported by an Australian Government Research Training Program Scholarship A.J.H. is a National Health and Medical Research Council (NHMRC) Principal Research Fellow and has been supported by an Australian Research Council (ARC) FT3 Future Fellowship (FT100100835). E.L.B. is supported by a NHMRC-ARC Dementia Research
Acknowledgements
We would like to thank past and present laboratory members for useful discussions and technical assistance. We thank Britany Cuic, Maddison Ible, Daniel Drieberg, Shannon Currin Craig Thompson and Brett Purcell for their assistance in mouse husbandry and management of equipment. Thank you to Nippy's Ltd, for the donation of Ice Strawberry milk to our study. A.S is supported by an Australian Government Research Training Program Scholarship and Yulgilbar top-up scholarship. A.M.Z.J is supported
CRediT authorship contribution statement
Amy Shepherd: Conceptualization, Methodology, Formal analysis, Investigation, Writing – original draft, Visualization, Writing – review & editing. Jeremiah K.H. Lim: Methodology, Formal analysis, Investigation, Writing – original draft, Visualization, Writing – review & editing. Vicky H.Y. Wong: Methodology, Investigation, Formal analysis, Supervision, Writing – review & editing. Ariel M. Zeleznikow-Johnston: Methodology, Software, Formal analysis, Writing – original draft, Writing – review &
References (71)
- et al.
Executive function deficits in early Alzheimer's disease and their relations with episodic memory
Arch. Clin. Neuropsychol
(2006) - et al.
A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease
Behav. Brain Res
(2011) - et al.
Novel behavioural characteristics of the APP(Swe)/PS1ΔE9 transgenic mouse model of Alzheimer's disease
Behav. Brain Res
(2013) - et al.
CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice
Alzheimers Res. Ther
(2019) - et al.
Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease
Brain Res
(2009) - et al.
Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease
Neuropharmacology
(2011) - et al.
Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD)
Behav. Brain Res
(2012) - et al.
Early locus coeruleus degeneration and olfactory dysfunctions in Tg2576 mice
Neurobiol. Aging
(2009) - et al.
Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse
Neurosci. Lett
(2016) - et al.
Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease
Neurobiol. Dis
(2007)
DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice
Neurobiol. Dis
Impaired conditioned taste aversion learning in APP transgenic mice
Neurobiol. Aging
Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav
Brain Res
Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model
NeuroImage
Effects of the genetic background on cognitive performances of TG2576 mice
Behav. Brain Res
Impaired context reversal learning, but not cue reversal learning, in patients with amnestic mild cognitive impairment
Neuropsychologia
Cognitive deficits in single App knock-in mouse models
Neurobiol. Learn. Mem
Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice
Neurosci. Lett
Behavioral effects of Rho GTPase modulation in a model of Alzheimer's disease. Behav
Brain Res
The aging rat retina: from function to anatomy
Neurobiol. Aging
Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels
Neurobiol. Aging
Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models
Neurobiol. Aging
Acquisition and reversal of visual discrimination learning in APPSwDI/Nos2−/− (CVN) mice
Neurosci. Lett
Maximum likelihood estimation of limited and discrete dependent variable models with nested random effects
J. Econom
A touch screen-automated cognitive test battery reveals impaired attention, memory abnormalities, and increased response inhibition in the TgCRND8 mouse model of Alzheimer's disease
Neurobiol. Aging
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to β-amyloid deposition and neurotransmitter abnormalities
Neurobiol. Dis
Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice
Neurobiol. Aging
Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Behav
Brain Res
Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease. Behav
Brain Res
Environmental enrichment enhances cognitive flexibility in C57BL/6 mice on a touchscreen reversal learning task
Neuropharmacology
Characterization of the circumlimbal suture model of chronic iop elevation in mice and assessment of changes in gene expression of stretch sensitive channels
Front. Neurosci
Preclinical prediction of AD using neuropsychological tests
J. Int. Neuropsychol. Soc
Differentiating between Alzheimer's disease and vascular cognitive impairment: is the “memory versus executive function” contrast still relevant?
J. Alzheimer's. Dis
Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology
Nat. Commun
Cited by (4)
Active Gains in brain Using Exercise During Aging (AGUEDA): protocol for a randomized controlled trial
2023, Frontiers in Human Neuroscience